Department of Emergency Medicine, Virginia Commonwealth University Medical Center, Medical College of Virginia Campus, Richmond, VA 23298-0401, USA.
Am J Emerg Med. 2012 Jul;30(6):872-80. doi: 10.1016/j.ajem.2011.06.005. Epub 2011 Aug 25.
The aim of this study was to measure sublingual perfused capillary density (PCD) to assess sublingual microvascular perfusion during emergency department (ED) treatment of acute decompensated heart failure (ADHF).
This prospective, observational study enrolled ED patients with ADHF, measuring pre- and post-ED treatment PCD. Sidestream dark-field imaging was analyzed by 3 investigators blinded to patient identifiers and time points. Patient demographics, ADHF etiology, serum brain natriuretic peptide, and hemoglobin were measured along with a visual analogue scale (VAS), which assessed patient baseline characteristics and response to ED treatment. A paired t test analyzed changes in PCD, mean arterial pressure (MAP), and patient assessment. Interrater variability was assessed with an intraclass correlation coefficient (ICC), with a P value <.05 considered significant for all testing.
Thirty-six patients were enrolled with a mean time between pretreatment and posttreatment PCD (±SD) of 138 ± 59 minutes and a hospital length of stay of 4.0 ± 4.1 days. During this time, PCD increased (difference, 1.3 mm/mm(2); 95% confidence interval, 0.4-2.1; P = .004), as did the MAP (P = .002), patient VAS score (P < .001), and observer VAS score (P < .001). There was no correlation between the change in PCD and time (R(2) = .016, P = .47), MAP (R(2) = .013, P = .54), or VAS scores. The ICC was 0.954.
Sublingual tissue perfusion is diminished in ADHF but increases with treatment. It may represent a quantitative way to evaluate ADHF in the ED setting.
本研究旨在测量舌下毛细血管灌注密度(PCD),以评估急性失代偿性心力衰竭(ADHF)在急诊科(ED)治疗过程中的舌下微血管灌注情况。
本前瞻性观察性研究纳入了 ED 中患有 ADHF 的患者,测量 ED 治疗前后的舌下 PCD。3 位观察者对患者标识符和时间点均不知情,对侧流暗场成像进行分析。测量患者的人口统计学、ADHF 病因、血清脑钠肽和血红蛋白,以及视觉模拟量表(VAS),以评估患者的基线特征和对 ED 治疗的反应。采用配对 t 检验分析 PCD、平均动脉压(MAP)和患者评估的变化。采用组内相关系数(ICC)评估组内变异,所有检验 P 值<.05 认为差异有统计学意义。
共纳入 36 例患者,治疗前后舌下 PCD 的平均时间(± SD)为 138±59 分钟,住院时间为 4.0±4.1 天。在此期间,PCD 增加(差异,1.3mm/mm2;95%置信区间,0.4-2.1;P=.004),MAP(P=.002)、患者 VAS 评分(P<.001)和观察者 VAS 评分(P<.001)也增加。PCD 的变化与时间(R2=0.016,P=.47)、MAP(R2=0.013,P=.54)或 VAS 评分之间无相关性。ICC 为 0.954。
ADHF 患者舌下组织灌注减少,但治疗后增加。它可能代表了一种在 ED 环境中评估 ADHF 的定量方法。